Rescue fusion hybridization
Rescue fusion hybridization is a process used to manufacture some therapeutic cancer vaccines in which individual tumor cells obtained through biopsy are fused with an antibody-secreting cell to form a heterohybridoma. This cell then secretes the unique idiotype, or immunoglobulin antigen characteristic of the individual tumor, which is purified for use as the vaccine.[1] It is used to produce the BiovaxID vaccine for follicular lymphoma.[citation needed]
References[edit]
- ^ "What Comes After Dendreon's Provenge?". 18 Oct 2010.
.svg){kind=small} | This biochemistry article is a stub. You can help Wikipedia by expanding it. |